Nikhil Amnerkar
NYSS Adv. V. R. Manohar Institute of Diploma in Pharmacy (Govt.-Aided)
0000-0002-9936-8758
About
* Medicinal chemists with 15+ years of professional experience in research, teaching, and administration
* Expertise in the synthesis of small molecules as selective inhibitors of enzyme targets involved in diabetes, cancer, microbial and viral infections.
* Experimental set-up strategies, solving laboratory-based problems, and time management in the delivery of project compounds.
* Extensive experience in modern drug design techniques (Computer-aided drug design, molecular modeling, 3D-QSAR, molecular docking, molecular dynamics simulation)
* Hands-on experience in molecular modeling software (Schrödinger, V-life sciences), sophisticated analytical instruments (IR, UV-Vis, HPLC, HPTLC), and project-related pharmacology instruments.
* Enjoy collaborating with interdisciplinary scientists to develop new skills and solve new challenges.
Employment
-
NYSS Adv. V. R. Manohar Institute of Diploma in Pharmacy (Govt.-Aided) Lecturer2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- Comprehensive Impact of Eaton's Reagent in Organic Synthesis: An Overview Save
- Natural compounds as PPAR-γ modulators in inflammatory bowel disease: Insights from molecular docking and dynamics simulations Save
- Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies Save
- Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: in silico molecular docking and dynamic simulation studies Save
- Hetero-substituted sulfonamido-benzamide hybrids as glucokinase activators: Design, synthesis, molecular docking and in-silico ADME evaluation Save
- Small interfering RNA for cancer treatment: overcoming hurdles in delivery Save
- 3D-QSAR Studies on 4,5-Dihydro-1H-pyrazolo [4,3-h] Quinazolines as Plk-1, CDK2/A and Aur-A Serine/Threonine Kinase Inhibitors Save
- Bio-analytical Assay Methods used in Therapeutic Drug Monitoring of Antiretroviral Drugs-A Review Save
- Emergence of Three Dimensional Printed Cardiac Tissue: Opportunities and Challenges in Cardiovascular Diseases Save
- Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction Save